Halozyme Therapeutics, Inc. (HALO)

Halozyme Therapeutics Stock Forecast

Stock Price Forecast

The 8 analysts with 12-month price forecasts for HALO stock have an average target of 57.25, with a low estimate of 40 and a high estimate of 71. The average target predicts an increase of 11.60% from the current stock price of 51.30.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$40	$57.25	$59	$71
Change	-22.03%	+11.60%	+15.01%	+38.40%

Analyst Ratings

The average analyst rating for HALO stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '24	Feb '24	Mar '24	Apr '24	May '24	Jun '24
Strong Buy	3	3	3	2	2	2
Buy	5	5	5	4	3	4
Hold	2	2	2	1	1	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	10	10	7	6	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $65	Strong Buy	Reiterates	$65	+26.71%	Jun 26, 2024
Robert Wasserman Benchmark	Benchmark	Strong Buy Maintains $50 → $60	Strong Buy	Maintains	$50 → $60	+16.96%	Jun 25, 2024
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $65	Strong Buy	Reiterates	$65	+26.71%	Jun 24, 2024
Joseph Catanzaro Piper Sandler	Piper Sandler	Buy → Hold Downgrades $48 → $51	Buy → Hold	Downgrades	$48 → $51	-0.58%	Jun 7, 2024
Mohit Bansal Wells Fargo	Wells Fargo	Buy Maintains $48 → $58	Buy	Maintains	$48 → $58	+13.06%	Jun 7, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

1.01B

Increased by 21.43%

from 829.25M

Revenue Next Year

1.17B

Increased by 16.29%

from 1.01B

EPS This Year

4.04

Increased by 92.51%

from 2.10

EPS Next Year

5.03

Increased by 24.52%

from 4.04

Year	2019	2020	2021	2022	2023	2024	2025	2026	2027	2028
Revenue	195.99M	267.59M	443.31M	660.12M	829.25M	1.01B	1.17B	1.42B	1.67B	1.78B
Revenue Growth	29.06%	36.53%	65.67%	48.91%	25.62%	21.43%	16.29%	21.35%	17.52%	6.35%
EPS	-0.50	0.91	2.74	1.44	2.10	4.04	5.03	6.49	8.00	8.64
EPS Growth	-	-	201.10%	-47.45%	45.83%	92.51%	24.52%	28.84%	23.30%	8.10%
Forward PE	-	-	-	-	-	12.69	10.19	7.91	6.42	5.93
No. Analysts	-	-	-	-	-	12	11	8	6	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026	2027	2028
High	1.1B	1.3B	1.5B	1.8B	1.9B
Avg	1.0B	1.2B	1.4B	1.7B	1.8B
Low	923.1M	1.1B	1.3B	1.5B	1.7B

Revenue Growth

Revenue Growth	2024	2025	2026	2027	2028
High	30.5%	26.3%	29.2%	24.1%	10.9%
Avg	21.4%	16.3%	21.3%	17.5%	6.3%
Low	11.3%	6.2%	14.3%	8.9%	-0.7%

EPS Forecast

EPS	2024	2025	2026	2027	2028
High	4.46	5.68	7.22	9.00	9.50
Avg	4.04	5.03	6.49	8.00	8.64
Low	3.68	4.59	5.91	7.28	7.71

EPS Growth

EPS Growth	2024	2025	2026	2027	2028
High	112.5%	40.5%	43.5%	38.7%	18.8%
Avg	92.5%	24.5%	28.8%	23.3%	8.1%
Low	75.0%	13.4%	17.4%	12.3%	-3.6%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.